A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/23/2002	CN1093127C 哌嗪衍生物 Piperazine derivatives
10/23/2002	CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/23/2002	CN1093122C Piperazine derivatives as 5-HTIA antagonists
10/23/2002	CN1092990C Modulation of cell proliferation and wound healing
10/23/2002	CN1092986C CoA oral preparation for reducing blood fat and its preparation method and application
10/23/2002	CN1092981C Medicine for curing arthralgia-syndrome resulted from wind, cold and damphess and its preparation method
10/23/2002	CN1092975C Cough relieving oral medicine
10/23/2002	CN1092973C Use of mastic or mastic lipophilia extract in preparation of drug for treatment of alzheimer's disease
10/23/2002	CN1092971C Chinese medicine for treating rheumatism
10/23/2002	CN1092967C Powdered medicine for treating simple baby diarrhea
10/23/2002	CN1092962C Analgesic for osteonosus and osteoarthropthy
10/23/2002	CN1092961C Pharmaceutical with anti-high-blood-sugar
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/23/2002	CN1092959C Pharmaceutical composition contg. tiagabine or receptive salt and process for its preparation
10/23/2002	CN1092958C Melatonic derivatives for use in treating sleep disorders
10/23/2002	CN1092957C Retarded-action microtable made of beta-phenylpropiophenone derivatives
10/23/2002	CN1092956C Sustained release drug formulation containing a tramadol salt
10/23/2002	CN1092955C Method of producing multi-layer medicaments in solid form for oral or rectal administration
10/23/2002	CN1092954C Ophthalamic compositions containing cyclotextrins and quatemary ammonium compound
10/23/2002	CN1092939C Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholis and preventing abuse of alcohol in healthy subjects
10/23/2002	CN1092938C Diabetic supplement bar
10/23/2002	CA2407472A1 Sustained release compositions
10/23/2002	CA2383149A1 Process for partially reducing or eliminating the symptoms associated with the release of histamine in the body
10/23/2002	CA2383115A1 Use of an effective amount of at least one ion chelating agent to enhance the tolerance level of sensitive or intolerant skin
10/23/2002	CA2381875A1 Multioligoanilinated fullerenes
10/23/2002	CA2381630A1 Method for preventing dyskinesias
10/22/2002	WO2001091753A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
10/22/2002	US6469213 Tramadol, salts thereof and process for their preparation
10/22/2002	US6469207 Hiv protease inhibitors; administering to treat aids (acquired immune deficiency syndrome)
10/22/2002	US6469187 Contaminant reduced marine oil
10/22/2002	US6469184 Coupling a cyclopentenone with a cyclic carbonyl ylide dipole
10/22/2002	US6469182 Intermediates in the preparation of macrocyclic analogs
10/22/2002	US6469180 3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1h -pyrrole-2,5,-dione which is substantially free of crystalline compound prepared by dissolving crystalline in a supercritical fluid then evaporating
10/22/2002	US6469174 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
10/22/2002	US6469171 Syntheses of a variety of lamellarin compounds and analogues
10/22/2002	US6469168 For the treatment of central nervous system disorders, especially anxiety
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469160 Crystalline forms of an antiviral benzimidazole compound
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6469070 Topical medicament comprising phenolic biocide and choline
10/22/2002	US6469069 Propofol composition containing sulfite
10/22/2002	US6469067 For treatment of livestock for parasites; comprises 1-(4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy) phenyl)-3-(2,6-difluorobenzoyl)urea and one of: ivermectin, doramectin, moxidectin and selamectin
10/22/2002	US6469066 Treating burns with one or more of acetic acid, vinegar and citric acid for prevention of delayed hyperalgesia
10/22/2002	US6469064 Treating depression and affective disorders, such as obsessive compulsive disorder in a patient by administering to the patient an effective amount of flavoxamine ester derivatives
10/22/2002	US6469063 Inhibition of inflammation via inhibition of COX-2 gene transcription
10/22/2002	US6469062 Use of 15-keto-prostaglandins in promoting bile secretion
10/22/2002	US6469061 Use of members of the plant stress hormone family termed ?jasmonates?, for suppressing and killing mammalian cancer cells that represent major types of human malignancies
10/22/2002	US6469058 For the treatment of nonsmall cell lung cancer
10/22/2002	US6469057 Methods for in vivo reduction of free radical levels and compositions useful therefor
10/22/2002	US6469056 Pharmaceutically active compounds, their preparation and use as ECE-inhibitors
10/22/2002	US6469055 Modulating expression, production, or formation of amyloid precursor protein by administering a nonsteroidal antiinflammatory agent that is a cyclooxygenase inhibitor
10/22/2002	US6469054 Aryl sulphonamides and analogues
10/22/2002	US6469053 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
10/22/2002	US6469052 Compounds for the photodecontamination of pathogens in blood
10/22/2002	US6469051 Diaminorhodamine derivative
10/22/2002	US6469050 7-hexanoyltaxol and methods for preparing the same
10/22/2002	US6469049 Administering a lipoic acid compound, such as alpha-lipoic acid, dihydrolipoic acid, or 2-(N,N-dimethylamino)ethylamido lipoate-HCL.
10/22/2002	US6469048 Bactericides; anticancer agents
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469046 Fabh inhibitors which are useful as antibiotics for the treatment of gram positive and gram negative bacterial infections
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469044 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
10/22/2002	US6469043 Antiangiogenic agent with antitumor, antimetastatic properties which shows high safety
10/22/2002	US6469041 Certain pyrazole derivatives as corticotropin-releasing factor CRF1 ligands
10/22/2002	US6469040 Administering 1-(p-aminosulfonyl)phenyl-3-haloalkyl-5-phenylpyrazoles
10/22/2002	US6469037 Prophylactic or therapeutic drug for renal diseases
10/22/2002	US6469035 Reducing the capacity of an extended release nicotinic acid to provoke a flushing reaction by orally pretreating with an agent which inhibits or reduces prostaglandin pgd2 induced by nicotinic acid; fda orange book listed patent for niacin and simvastatin
10/22/2002	US6469034 Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase
10/22/2002	US6469033 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
10/22/2002	US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002	US6469031 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/22/2002	US6469030 Methods for the treatment and prevention of ileus
10/22/2002	US6469029 Azacycloalkanone serine protease inhibitors
10/22/2002	US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002	US6469027 N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
10/22/2002	US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469022 By inhibition of the p-glycoprotein efflux pump, a multidrug transporter, in the intestinal mucosa; allowing intracellular accumulation of drug
10/22/2002	US6469021 Non-peptide antagonists of GLP-1 receptor and methods of use
10/22/2002	US6469020 Hydroxamic and carboxylic acid derivatives
10/22/2002	US6469019 Prevention/treatment of motor neuron diseases; amyotrophic lateral sclerosis
10/22/2002	US6469018 Compounds
10/22/2002	US6469017 Method of inhibiting interleukin-12 signaling
10/22/2002	US6469016 Treatment of female sexual dysfunction using phosphodiesterase inhibitors
10/22/2002	US6469015 Suitable for use in the treatment of virus infections of the skin and mucosa, such as herpes
10/22/2002	US6469013 Therapeutic compounds
10/22/2002	US6469012 Pyrazolopyrimidinones for the treatment of impotence
10/22/2002	US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
10/22/2002	US6469009 Mixture consisting essentially of pseudoephedrine and compound selected from 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acid or amide derivatives, their individual optical isomers or pharmaceutically acceptable salts
10/22/2002	US6469008 (R)-hydroxynefazodone antipsychotic therapy
10/22/2002	US6469007 P-substituted-n-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-n-pyridin-2-yl-benzamide,
10/22/2002	US6469006 Particularly for treating hiv infections
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002	US6469001 IL-5 inhibiting 6-azauracil derivatives
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/22/2002	US6468999 Treating anxiety, depression and other central nervous system disorders in humans and animals
10/22/2002	US6468997 Desmethylolanzapine compositions and methods
10/22/2002	US6468994 Budesonide particles and pharmaceutical compositions containing them

1 ... 5674 5675 5676 5677 5678 5679 5680 5681 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 ... 7860